TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today: Echo Therapeutics ( ECTE) is one of the companies that ... to its average daily volume of 43,300 shares. The stock ranged in a price between $1.46-$1.66 after ...
The Street · 8/21/2015
During the same quarter last year, the firm earned ($0.36) EPS. Shares of Echo Therapeutics (NASDAQ:ECTE) opened at 1.51 on Friday. The stock’s market cap is $16.80 million. The stock has a 50 day moving average of $1.66 and a 200 day moving … · 8/15/2015
Echo Therapeutics (NASDAQ:ECTE) traded down 2.58% during midday trading on Friday, reaching $1.51. The company’s stock had a trading volume of 30,993 shares. The company’s market cap is $16.80 million. The stock has a 50-day moving average … · 8/14/2015
More from Bing News
Echo Therapeutics (NASDAQ:ECTE) traded down 2.58% on Friday, hitting $1.51. 30,993 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $1.67 and a 200-day moving average price of $1.93. Echo …
Ticker Report · 8/14/2015
The spike — even as high as it was — still keeps ECTE stock down some 57% year to date. Echo Therapeutics, Inc. (Echo) is a transdermal medical device company. Article printed from InvestorPlace Media, http://investorplace.
Investor Place · 11/26/2013
Echo Therapeutics, Inc. (Nasdaq: ECTE) announced that a 1-for-10 reverse split of the Company's issued and outstanding common stock will be effective prior to the market opening on Friday, June 7, 2013. Beginning with the opening of trading on June 7 ...
StreetInsider · 6/6/2013
These stocks are making interesting moves on high volume. USMD Holdings Inc. (USMD) traded at $15.16 – 0.79 (4.95 percent). USMD Holdings Inc. (USMD) < is +37.64 percent for the past 30 days, +37.82 percent year-to-date, and -12.49 percent over …
Fx Pips · 2/4/2015
Nov 26, 2013 (ACCESSWIRE via COMTEX) -- New York, NY - (ACCESSWIRE) - 11/26/2013 - Equity Profile Report initiates its NASDAQ Active Stock Weekly Watch List adding ... 1.08% and Echo Therapeutics, Inc. ECTE, +2.41% Sprouts Farmers Market …
Market Watch · 11/27/2013
The letter detailed a multi-point plan the New York-based investor group believes would return the market value of the company's stock. ECTE's share price has declined over 95% during the past two years. Among Platinum-Montaur's proposals would be …
NASDAQ · 8/30/2013
Given the prospects of the deal, ECTE’s major shareholder, Platinum Montaur has decided to invest in 69,569 shares of its common stock for $2.75 per share. These equity investments will result in total equity investment of $10 million in Echo Therapeutics.
Yahoo Finance · 12/17/2013